- vaccine: BNT162b2
  dosage: 1.0
  infection: ''
  num_ref_name: 28
  num_fold: 4163
  S: 3177
  I: 802
  R: 184
  median_fold: 2.0
  percent: 2.8
  priority: 1
- vaccine: BNT162b2
  dosage: 1.0
  infection: infected
  num_ref_name: 24
  num_fold: 1273
  S: 891
  I: 346
  R: 36
  median_fold: 3.0
  percent: 0.86
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 183
  num_fold: 22372
  S: 15363
  I: 5148
  R: 1861
  median_fold: 2.9
  percent: 15.0
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 54
  num_fold: 4317
  S: 2451
  I: 1543
  R: 323
  median_fold: 4.0
  percent: 2.9
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 86
  num_fold: 8025
  S: 4191
  I: 3064
  R: 770
  median_fold: 4.5
  percent: 5.4
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: infected
  num_ref_name: 24
  num_fold: 2260
  S: 1302
  I: 689
  R: 269
  median_fold: 4.0
  percent: 1.5
  priority: 1
- vaccine: BNT162b2
  dosage: 4.0
  infection: ''
  num_ref_name: 7
  num_fold: 499
  S: 50
  I: 215
  R: 234
  median_fold: 23.0
  percent: 0.34
  priority: 1
- vaccine: BNT162b2
  dosage: 4.0
  infection: infected
  num_ref_name: 3
  num_fold: 268
  S: 40
  I: 126
  R: 102
  median_fold: 16.0
  percent: 0.18
  priority: 1
- vaccine: mRNA-1273
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 155
  S: 131
  I: 24
  R: 0
  median_fold: 1.5
  percent: 0.1
  priority: 2
- vaccine: mRNA-1273
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 14
  S: 7
  I: 4
  R: 3
  median_fold: 5.3
  percent: 0.0094
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 68
  num_fold: 9358
  S: 6213
  I: 2586
  R: 559
  median_fold: 3.9
  percent: 6.3
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: infected
  num_ref_name: 12
  num_fold: 468
  S: 312
  I: 126
  R: 30
  median_fold: 3.1
  percent: 0.32
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 23
  num_fold: 4443
  S: 2909
  I: 1454
  R: 80
  median_fold: 4.5
  percent: 3.0
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: infected
  num_ref_name: 8
  num_fold: 524
  S: 257
  I: 254
  R: 13
  median_fold: 5.1
  percent: 0.35
  priority: 2
- vaccine: mRNA-1273
  dosage: 4.0
  infection: ''
  num_ref_name: 3
  num_fold: 532
  S: 260
  I: 269
  R: 3
  median_fold: 12.0
  percent: 0.36
  priority: 2
- vaccine: mRNA-1273
  dosage: 4.0
  infection: infected
  num_ref_name: 2
  num_fold: 295
  S: 114
  I: 153
  R: 28
  median_fold: 5.5
  percent: 0.2
  priority: 2
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: ''
  num_ref_name: 22
  num_fold: 1598
  S: 1097
  I: 416
  R: 85
  median_fold: 3.0
  percent: 1.1
  priority: 3
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: infected
  num_ref_name: 8
  num_fold: 198
  S: 141
  I: 48
  R: 9
  median_fold: 2.6
  percent: 0.13
  priority: 3
- vaccine: Ad26.COV2.S
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 558
  S: 289
  I: 253
  R: 16
  median_fold: 4.6
  percent: 0.38
  priority: 3
- vaccine: AZD1222
  dosage: 1.0
  infection: ''
  num_ref_name: 10
  num_fold: 1752
  S: 689
  I: 559
  R: 504
  median_fold: 6.0
  percent: 1.2
  priority: 4
- vaccine: AZD1222
  dosage: 1.0
  infection: infected
  num_ref_name: 4
  num_fold: 680
  S: 587
  I: 93
  R: 0
  median_fold: 3.3
  percent: 0.46
  priority: 4
- vaccine: AZD1222
  dosage: 2.0
  infection: ''
  num_ref_name: 40
  num_fold: 3676
  S: 1968
  I: 1076
  R: 632
  median_fold: 4.6
  percent: 2.5
  priority: 4
- vaccine: AZD1222
  dosage: 2.0
  infection: infected
  num_ref_name: 14
  num_fold: 1847
  S: 1212
  I: 519
  R: 116
  median_fold: 3.6
  percent: 1.2
  priority: 4
- vaccine: AZD1222
  dosage: 3.0
  infection: ''
  num_ref_name: 6
  num_fold: 990
  S: 211
  I: 779
  R: 0
  median_fold: 6.8
  percent: 0.67
  priority: 4
- vaccine: BBIBP-CorV
  dosage: 2.0
  infection: ''
  num_ref_name: 12
  num_fold: 3147
  S: 1933
  I: 879
  R: 335
  median_fold: 3.4
  percent: 2.1
  priority: 6
- vaccine: BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 552
  S: 113
  I: 438
  R: 1
  median_fold: 20.0
  percent: 0.37
  priority: 6
- vaccine: BBV152
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 477
  S: 449
  I: 7
  R: 21
  median_fold: 1.4
  percent: 0.32
  priority: 7
- vaccine: BBV152
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 170
  S: 151
  I: 0
  R: 19
  median_fold: 2.4
  percent: 0.11
  priority: 7
- vaccine: CoronaVac
  dosage: 1.0
  infection: ''
  num_ref_name: 3
  num_fold: 220
  S: 220
  I: 0
  R: 0
  median_fold: 1.5
  percent: 0.15
  priority: 8
- vaccine: CoronaVac
  dosage: 1.0
  infection: infected
  num_ref_name: 3
  num_fold: 390
  S: 242
  I: 148
  R: 0
  median_fold: 3.3
  percent: 0.26
  priority: 8
- vaccine: CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 21
  num_fold: 2376
  S: 1600
  I: 717
  R: 59
  median_fold: 3.1
  percent: 1.6
  priority: 8
- vaccine: CoronaVac
  dosage: 2.0
  infection: infected
  num_ref_name: 7
  num_fold: 250
  S: 136
  I: 74
  R: 40
  median_fold: 4.7
  percent: 0.17
  priority: 8
- vaccine: CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 18
  num_fold: 5395
  S: 1225
  I: 2954
  R: 1216
  median_fold: 12.0
  percent: 3.6
  priority: 8
- vaccine: CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 8
  num_fold: 12044
  S: 2519
  I: 5626
  R: 3899
  median_fold: 14.0
  percent: 8.1
  priority: 8
- vaccine: NVX-CoV2373
  dosage: 2.0
  infection: ''
  num_ref_name: 4
  num_fold: 275
  S: 110
  I: 103
  R: 62
  median_fold: 8.1
  percent: 0.19
  priority: 9
- vaccine: NVX-CoV2373
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 212
  S: 48
  I: 164
  R: 0
  median_fold: 8.2
  percent: 0.14
  priority: 9
- vaccine: ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 7
  num_fold: 716
  S: 210
  I: 461
  R: 45
  median_fold: 8.1
  percent: 0.48
  priority: 10
- vaccine: mRNA-1273 + mRNA-1273.211
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 4882
  S: 4850
  I: 32
  R: 0
  median_fold: 2.3
  percent: 3.3
  priority: 24
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 423
  S: 170
  I: 250
  R: 3
  median_fold: 7.4
  percent: 0.28
  priority: 34
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: infected
  num_ref_name: 8
  num_fold: 403
  S: 275
  I: 66
  R: 62
  median_fold: 3.0
  percent: 0.27
  priority: 34
- vaccine: BNT162b2 + mRNA-1273
  dosage: 4.0
  infection: ''
  num_ref_name: 3
  num_fold: 66
  S: 11
  I: 21
  R: 34
  median_fold: 32.0
  percent: 0.044
  priority: 34
- vaccine: BNT162b2 + mRNA-1273
  dosage: 4.0
  infection: infected
  num_ref_name: 2
  num_fold: 14
  S: 6
  I: 1
  R: 7
  median_fold: 21.0
  percent: 0.0094
  priority: 34
- vaccine: BNT162b2 + BNT162b2_BA.4/5_bivalent
  dosage: 4.0
  infection: ''
  num_ref_name: 2
  num_fold: 141
  S: 36
  I: 57
  R: 48
  median_fold: 16.0
  percent: 0.095
  priority: 39
- vaccine: mRNA-monovalent
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 79
  S: 22
  I: 55
  R: 2
  median_fold: 10.0
  percent: 0.053
  priority: 47
- vaccine: mRNA-monovalent
  dosage: 2.0
  infection: infected
  num_ref_name: 5
  num_fold: 264
  S: 141
  I: 105
  R: 18
  median_fold: 2.8
  percent: 0.18
  priority: 47
- vaccine: mRNA-monovalent
  dosage: 3.0
  infection: ''
  num_ref_name: 13
  num_fold: 1379
  S: 322
  I: 583
  R: 474
  median_fold: 14.0
  percent: 0.93
  priority: 47
- vaccine: mRNA-monovalent
  dosage: 3.0
  infection: infected
  num_ref_name: 11
  num_fold: 2502
  S: 1171
  I: 800
  R: 531
  median_fold: 6.0
  percent: 1.7
  priority: 47
- vaccine: mRNA-monovalent
  dosage: 4.0
  infection: ''
  num_ref_name: 3
  num_fold: 414
  S: 38
  I: 207
  R: 169
  median_fold: 15.0
  percent: 0.28
  priority: 47
- vaccine: mRNA-monovalent
  dosage: 4.0
  infection: infected
  num_ref_name: 2
  num_fold: 275
  S: 120
  I: 70
  R: 85
  median_fold: 9.4
  percent: 0.19
  priority: 47
- vaccine: mRNA-bivalent + mRNA-monovalent
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 138
  S: 54
  I: 68
  R: 16
  median_fold: 6.9
  percent: 0.093
  priority: 48
- vaccine: mRNA-bivalent + mRNA-monovalent
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 110
  S: 44
  I: 55
  R: 11
  median_fold: 8.0
  percent: 0.074
  priority: 48
- vaccine: mRNA-bivalent + mRNA-monovalent
  dosage: 4.0
  infection: ''
  num_ref_name: 8
  num_fold: 1356
  S: 174
  I: 648
  R: 534
  median_fold: 18.0
  percent: 0.91
  priority: 48
- vaccine: mRNA-bivalent + mRNA-monovalent
  dosage: 4.0
  infection: infected
  num_ref_name: 3
  num_fold: 185
  S: 30
  I: 81
  R: 74
  median_fold: 17.0
  percent: 0.12
  priority: 48
- vaccine: Convidecia
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 215
  S: 215
  I: 0
  R: 0
  median_fold: 1.4
  percent: 0.14
  priority: 50
- vaccine: Sputnik V
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 592
  S: 408
  I: 142
  R: 42
  median_fold: 4.0
  percent: 0.4
  priority: 52
- vaccine: AZD1222 + Sputnik V
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 104
  S: 28
  I: 76
  R: 0
  median_fold: 9.5
  percent: 0.07
  priority: 54
- vaccine: KCONVAC
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 251
  S: 241
  I: 10
  R: 0
  median_fold: 1.2
  percent: 0.17
  priority: 56
- vaccine: CoronaVac or BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 588
  S: 541
  I: 47
  R: 0
  median_fold: 4.2
  percent: 0.4
  priority: 57
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 225
  S: 98
  I: 107
  R: 20
  median_fold: 7.5
  percent: 0.15
  priority: 64
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 6
  S: 6
  I: 0
  R: 0
  median_fold: 0.65
  percent: 0.004
  priority: 64
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 552
  S: 425
  I: 127
  R: 0
  median_fold: 2.6
  percent: 0.37
  priority: 64
- vaccine: Ad26.COV2.S + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 270
  S: 135
  I: 135
  R: 0
  median_fold: 5.4
  percent: 0.18
  priority: 65
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 12
  num_fold: 1862
  S: 544
  I: 468
  R: 850
  median_fold: 12.0
  percent: 1.3
  priority: 68
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 12
  S: 6
  I: 5
  R: 1
  median_fold: 4.9
  percent: 0.0081
  priority: 68
- vaccine: AZD1222 + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 9
  num_fold: 1187
  S: 459
  I: 482
  R: 246
  median_fold: 7.9
  percent: 0.8
  priority: 68
- vaccine: AZD1222 + BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 89
  S: 89
  I: 0
  R: 0
  median_fold: 2.6
  percent: 0.06
  priority: 69
- vaccine: AZD1222 + CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 209
  S: 120
  I: 29
  R: 60
  median_fold: 3.3
  percent: 0.14
  priority: 70
- vaccine: AZD1222 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 875
  S: 698
  I: 167
  R: 10
  median_fold: 2.6
  percent: 0.59
  priority: 70
- vaccine: AZD1222 + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 268
  S: 187
  I: 63
  R: 18
  median_fold: 4.5
  percent: 0.18
  priority: 73
- vaccine: AZD1222 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 680
  S: 560
  I: 120
  R: 0
  median_fold: 1.8
  percent: 0.46
  priority: 73
- vaccine: BBIBP-CorV + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 149
  S: 113
  I: 36
  R: 0
  median_fold: 3.5
  percent: 0.1
  priority: 76
- vaccine: BBIBP-CorV + ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 252
  S: 52
  I: 182
  R: 18
  median_fold: 7.8
  percent: 0.17
  priority: 78
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 12
  num_fold: 1398
  S: 978
  I: 405
  R: 15
  median_fold: 2.6
  percent: 0.94
  priority: 80
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 3
  num_fold: 324
  S: 244
  I: 76
  R: 4
  median_fold: 2.0
  percent: 0.22
  priority: 80
- vaccine: CoronaVac + ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 469
  S: 228
  I: 164
  R: 77
  median_fold: 6.4
  percent: 0.32
  priority: 87
- vaccine: CoronaVac + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 98
  S: 98
  I: 0
  R: 0
  median_fold: 4.2
  percent: 0.066
  priority: 88
- vaccine: BNT162b2 or AZD1222 + mRNA-monovalent
  dosage: 4.0
  infection: ''
  num_ref_name: 2
  num_fold: 60
  S: 0
  I: 30
  R: 30
  median_fold: 31.0
  percent: 0.04
  priority: 97
- vaccine: mRNA-bivalent + Unknown vaccine
  dosage: 4.0
  infection: ''
  num_ref_name: 2
  num_fold: 72
  S: 23
  I: 13
  R: 36
  median_fold: 34.0
  percent: 0.048
  priority: 98
- vaccine: Unknown vaccine
  dosage: 1.0
  infection: infected
  num_ref_name: 3
  num_fold: 244
  S: 116
  I: 107
  R: 21
  median_fold: 6.7
  percent: 0.16
  priority: 100
- vaccine: Unknown vaccine
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 528
  S: 320
  I: 177
  R: 31
  median_fold: 3.2
  percent: 0.36
  priority: 100
- vaccine: Unknown vaccine
  dosage: 2.0
  infection: infected
  num_ref_name: 11
  num_fold: 1039
  S: 839
  I: 136
  R: 64
  median_fold: 2.2
  percent: 0.7
  priority: 100
- vaccine: Unknown vaccine
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 78
  S: 32
  I: 43
  R: 3
  median_fold: 7.2
  percent: 0.053
  priority: 100
- vaccine: Unknown vaccine
  dosage: 3.0
  infection: infected
  num_ref_name: 12
  num_fold: 1017
  S: 706
  I: 245
  R: 66
  median_fold: 2.8
  percent: 0.68
  priority: 100
